Form 8-K for PATRIOT SCIENTIFIC CORP

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fs2006

Rank: President [?]

Points: 6748 [?]

Votes: 86 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Form 8-K for PATRIOT SCIENTIFIC CORP

posted on May 21, 2015 05:00PM

21-May-2015

Termination of a Material Definitive Agreement

Item 1.02 Termination of a Material Definitive Agreement.

Effective May 15, 2015, the joint venture of Patriot Scientific Corporation (the "Company") and Technology Properties Limited LLC ("TPL"), known as Phoenix Digital Solutions, LLC, a Delaware limited liability company ("PDS"), terminated the Amended Alliacense Services and Novation Agreement effective July 24, 2014 (the "Agreement") between PDS and Alliacense Limited LLC, a Delaware limited liability company ("Alliacense").

Under the Agreement, Alliacense was one of two companies that assist PDS with commercializing the Moore Microprocessor Patent portfolio (the "MMP Portfolio") through licensing and litigation on behalf of PDS, TPL, and the Company. The Agreement sets forth Alliacense's obligations and compensation in connection with its activities with respect to the MMP Portfolio. PDS terminated the Agreement due to Alliacense's failure to comply with its obligations under the Agreement.

The other licensing company, Dominion Harbor Group, LLC, continues to assist PDS with commercialization of the MMP Portfolio.